Epstein Secrets

ve Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983 and became a Vice President in 1988. Mr. Windreich holds both a B.A. in Economics and an . in F

MANAGEMENT GROUP ICS Investment Committee — U.S. David Windreich—EMD, Head of U.S. and European Investing, Member of Partner Management Committee Harold Kelly— EMD, Head of Global Convertible and Derivative Arbitrage and Risk Management, Member of Partner Management Committee Brett Klein—EMD, Head of U.S.

ve Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983 and became a Vice President in 1988. Mr. Windreich holds both a B.A. in Economics and an M.B.A.

les. He is a member of the Advisory Board of UCLA Anderson Fink Center for Finance and Investments and a Trustee of The Mount Sinai Medical Center. Harold Kelly is Head of Global Convertible and Derivative Arbitrage and Risk Management for Och-Ziff and is a member of Och-Ziff's Partner Management Committee.

ve Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983 and became a Vice President in 1988. Mr. Windreich holds both a B.A. in Economics and an M.B.A.

les. He is a member of the Advisory Board of UCLA Anderson Fink Center for Finance and Investments and a Trustee of The Mount Sinai Medical Center. Harold Kelly is Head of Global Convertible and Derivative Arbitrage and Risk Management for Och-Ziff and is a member of Och-Ziff's Partner Management Committee.

is the investment manager ("GSIS" or the "Investment Manager") of the Partnership. Both the General Partner and Investment Manager are affiliates of Goldman, Sachs & Co. ("Goldman Sachs.). The Partnership commenced operations on January 1, 2008 and will continue in existence until dissolved in accordance with the ter

anager exhibits significant depth of fundamental research capabilities and typically generates alpha from the long side. Daniel Och David Windreich, Harold Kelly, Joel Frank, MorganStanley SmithBarney 133 EFTA00283585 Mortimer B. Zuckerman and Related Entities Descriptions Of Investments For MBZ And Rel